Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.

@article{Botchorishvili2009EarlyPA,
  title={Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.},
  author={George Botchorishvili and Mika P. Matikainen and Hans Lilja},
  journal={Current opinion in urology},
  year={2009},
  volume={19 3},
  pages={
          221-6
        }
}
PURPOSE OF REVIEW To delineate how recent findings on prostate-specific antigen (PSA) can improve prediction of risk, detection, and prediction of clinical endpoints of prostate cancer (PCa). RECENT FINDINGS The widely used PSA cut-point of 4.0 ng/ml increasingly appears arbitrary, but no cut-point achieves both high sensitivity and high specificity. The accuracy of detecting PCa can be increased by additional predictive factors and a combinations of markers. Evidence implies that a panel of… CONTINUE READING
BETA

Similar Papers

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 15 CITATIONS

A Review of Imaging Methods for Prostate Cancer Detection

  • Biomedical engineering and computational biology
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 85 REFERENCES

Clinical impact of new prostate - specific antigen WHO standardization on biopsy rates and cancer detection

RJ Sotelo, KE Mora, LH Perez
  • Clin Chem
  • 2008